HER2Low

Publikationen

2018

Breunig, C., Erdem, N., Bott, A., Greiwe, J.F., Reinz, E., Bernhardt, S., Giacomelli, C., Wachter, A., Kanthelhardt, E.J., Beißbarth, T., Vetter, M., Wiemann, S., 2018. TGFβ1 regulates HGF-induced cell migration and hepatocyte growth factor receptor MET expression via C-ets-1 and miR-128-3p in basal-like breast cancer. Mol Oncol 12, 1447–1463. doi.org/10.1002/1878-0261.12355

Perera-Bel, J., Hutter, B., Heining, C., Bleckmann, A., Fröhlich, M., Fröhling, S., Glimm, H., Brors, B., Beißbarth, T., 2018. From somatic variants towards precision oncology: Evidence-driven reporting of treatment options in molecular tumor boards. Genome Med 10, 18. doi.org/10.1186/s13073-018-0529-2

Wolff, A., Bayerlová, M., Gaedcke, J., Kube, D., Beißbarth, T., 2018. A comparative study of RNA-Seq and microarray data analysis on the two examples of rectal-cancer patients and Burkitt Lymphoma cells. PLoS ONE 13, e0197162. https://doi.org/10.1371/journal.pone.0197162

2017

Bernhardt, S., Bayerlová, M., Vetter, M., Wachter, A., Mitra, D., Hanf, V., Lantzsch, T., Uleer, C., Peschel, S., John, J., Buchmann, J., Weigert, E., Bürrig, K.-F., Thomssen, C., Korf, U., Beissbarth, T., Wiemann, S., Kantelhardt, E.J., 2017. Proteomic profiling of breast cancer metabolism identifies SHMT2 and ASCT2 as prognostic factors. Breast Cancer Res. 19, 112. doi.org/10.1186/s13058-017-0905-7

Bott, A., Erdem, N., Lerrer, S., Hotz-Wagenblatt, A., Breunig, C., Abnaof, K., Wörner, A., Wilhelm, H., Münstermann, E., Ben-Baruch, A., Wiemann, S., 2017. miRNA-1246 induces pro-inflammatory responses in mesenchymal stem/stromal cells by regulating PKA and PP2A. Oncotarget 8, 43897–43914. doi.org/10.18632/oncotarget.14915

Golan-Lavi, R., Giacomelli, C., Fuks, G., Zeisel, A., Sonntag, J., Sinha, S., Köstler, W., Wiemann, S., Korf, U., Yarden, Y., Domany, E., 2017. Coordinated Pulses of mRNA and of Protein Translation or Degradation Produce EGF-Induced Protein Bursts. Cell Rep 18, 3129–3142. doi.org/10.1016/j.celrep.2017.03.014

Peckys, D.B., Korf, U., Wiemann, S., de Jonge, N., 2017. Liquid-phase electron microscopy of molecular drug response in breast cancer cells reveals irresponsive cell subpopulations related to lack of HER2 homodimers. Mol. Biol. Cell. doi.org/10.1091/mbc.E17-06-0381

2016

von der Heyde, S., Sonntag, J., Kramer, F., Bender, C., Korf, U., Beißbarth, T., 2016. Reconstruction of Protein Networks Using Reverse-Phase Protein Array Data. Methods Mol. Biol. 1362, 227–246. doi.org/10.1007/978-1-4939-3106-4_15

2015

 

Bayerlová, M., Klemm, F., Kramer, F., Pukrop, T., Beißbarth, T., Bleckmann, A., 2015. Newly Constructed Network Models of Different WNT Signaling Cascades Applied to Breast Cancer Expression Data. PLoS ONE 10, e0144014. doi.org/10.1371/journal.pone.0144014

von der Heyde, S., Wagner, S., Czerny, A., Nietert, M., Ludewig, F., Salinas-Riester, G., Arlt, D., Beißbarth, T., 2015. mRNA profiling reveals determinants of trastuzumab efficiency in HER2-positive breast cancer. PLoS ONE 10, e0117818. doi.org/10.1371/journal.pone.0117818

Wachter, A., Bernhardt, S., Beissbarth, T., Korf, U., 2015. Analysis of Reverse Phase Protein Array Data: From Experimental Design towards Targeted Biomarker Discovery. Microarrays 4, 520–539. doi.org/10.3390/microarrays4040520